Melanie Chartier

3 Rue Joseph Monier
Rueil-malmaison, 92500, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Treatment sequences of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: A nationwide population-based study in France.

Treatment sequences of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: A nationwide population-based study in France.

Journal: Joint bone spine

Published: May 26, 2025

Incidence and Burden of Lower-Risk Myelodysplastic Syndrome: A Nationwide Population Study.

Incidence and Burden of Lower-Risk Myelodysplastic Syndrome: A Nationwide Population Study.

Journal: Clinical lymphoma, myeloma & leukemia

Published: April 03, 2025

Immunosuppressive treatment patterns in kidney transplant recipients in France: an insurance claims database study (OISTER) over a 12 year period.

Immunosuppressive treatment patterns in kidney transplant recipients in France: an insurance claims database study (OISTER) over a 12 year period.

Journal: Journal of nephrology

Published: March 17, 2025

Epidemiology, patient management, and survival outcomes in resected patients with non-metastatic non-small cell lung cancer: a nationwide real-world study.

Epidemiology, patient management, and survival outcomes in resected patients with non-metastatic non-small cell lung cancer: a nationwide real-world study.

Journal: BMC cancer

Published: July 01, 2024

Two-year treatment persistence with subcutaneous abatacept in rheumatoid arthritis: results from the French cohort of the ASCORE study.

Two-year treatment persistence with subcutaneous abatacept in rheumatoid arthritis: results from the French cohort of the ASCORE study.

Journal: Clinical and experimental rheumatology

Published: August 07, 2023

Subcutaneous abatacept for the treatment of rheumatoid arthritis in routine clinical practice in Germany, Austria, and Switzerland: 2-year retention and efficacy by treatment line and serostatus.

Subcutaneous abatacept for the treatment of rheumatoid arthritis in routine clinical practice in Germany, Austria, and Switzerland: 2-year retention and efficacy by treatment line and serostatus.

Journal: Clinical rheumatology

Published: February 27, 2023

Population characteristics, management, and survival outcomes in muscle-invasive urothelial carcinoma undergoing radical resection: the MINOTAUR study.

Population characteristics, management, and survival outcomes in muscle-invasive urothelial carcinoma undergoing radical resection: the MINOTAUR study.

Journal: World journal of urology

Published: December 07, 2022

Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study.

Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study.

Journal: Clinical rheumatology

Published: November 19, 2021

Up to 5-year retention of abatacept in Belgian patients with moderate-to-severe rheumatoid arthritis: a sub-analysis of the international, observational ACTION study.

Up to 5-year retention of abatacept in Belgian patients with moderate-to-severe rheumatoid arthritis: a sub-analysis of the international, observational ACTION study.

Journal: Rheumatology international

Published: February 20, 2020

Two-year abatacept retention rate in clinical practice in the French ACTION cohort.

Two-year abatacept retention rate in clinical practice in the French ACTION cohort.

Journal: Joint bone spine

Published: June 12, 2019

Correction to: Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study.

Correction to: Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study.

Journal: Clinical rheumatology

Published: April 12, 2019

Abatacept retention and clinical outcomes in Austrian patients with rheumatoid arthritis: real-world data from the 2-year ACTION study.

Abatacept retention and clinical outcomes in Austrian patients with rheumatoid arthritis: real-world data from the 2-year ACTION study.

Journal: Wiener medizinische Wochenschrift (1946)

Published: March 27, 2019

Showing 1-12 of 24

Last Updated: 09/26/2026